CN101766734B - Medicine for treating prostatitis - Google Patents

Medicine for treating prostatitis Download PDF

Info

Publication number
CN101766734B
CN101766734B CN 200810073044 CN200810073044A CN101766734B CN 101766734 B CN101766734 B CN 101766734B CN 200810073044 CN200810073044 CN 200810073044 CN 200810073044 A CN200810073044 A CN 200810073044A CN 101766734 B CN101766734 B CN 101766734B
Authority
CN
China
Prior art keywords
parts
medicine
days
weight
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 200810073044
Other languages
Chinese (zh)
Other versions
CN101766734A (en
Inventor
胡翠华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200810073044 priority Critical patent/CN101766734B/en
Publication of CN101766734A publication Critical patent/CN101766734A/en
Application granted granted Critical
Publication of CN101766734B publication Critical patent/CN101766734B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

Disclosed is a medicine for treating prostatitis, which is characterized in that the medicine is prepared from the following ingredients in parts by weight: 20 parts of clematis root, 20 parts of amber, 18 parts of fructus akebiae, 30 parts of Chinese starjasmine stem, 18 parts of songaria cynomorium herb, 20 parts of dandelion and 20 parts of Chinese violet. The medicine is prepared by the following steps of crashing, sieving through 200 mesh, evenly mixing, weighting, adding 70 DEG distilled liquor with the same weight to infuse for 7 days in summer and 15 days in winter. The invention is a traditional Chinese medicine for external application, which has the advantages of no toxic side effect and good efficacy and can be used for treating the prostatitis.

Description

The prostatitic medicine of a kind of treatment
One, technical field
The present invention relates to a kind of prostatitic medicine of treatment with the preparation of Chinese medicine method.
Two, background technology
Prostatitis is meant the active chronic inflammation due to prostate specific and the non-special infection, and it is a kind of commonly encountered diseases.Prostatitis has following performance usually: urine flow point drop drips dysuria; Testis has mucus to occur, and is moist everyday, scent of, and urinating has bifurcated, and the BAIPAO foam is arranged, and urinary tract has Flos Cannabis type shape, and acute contraction urine is arranged, and waits for unablely again, and urine stream causes discomfort, and urine has secretions to mix seminal fluid; Root pain in the prostatic, penis, the thigh root, the trident district expands painful, and the rear portion has between waist, and the acid of both legs rear side is expanded, thereby has increased the weight of pain, and this sick treatment is untimely can suppurate, and might cause uremia.Prostate hyperplasia, bladder all the time can't safe emptyings, and sedimentary urine can be brought out infection, when the urine pressurized of outflow, and the inner increased pressure of bladder, kidney and ureter can be affected, and cause renal infection easily.The scorching normal antibiotics that adopts in western medical treatment prostatitis, recently, the scholar who has classifies antibiotic according to disperse entering the uneven difference of prostatic antimicrobial drug.Under the high level trimethoprim, clindamycin, erythromycin etc. are arranged; Medium level chloromycetin, lincomycin arranged; Low-level have ampicillin, Cefalotinsodium number, pioneer's IV number, doxycycline, kanamycin, nitrofurantoin, oxytetracycline, benzylpenicillin, polymyxin B, rifampicin and most sulphonamidess etc.The western medical treatment curative effect is fast, but is easy to generate side effect, injures kidney.How Chinese traditional treatment is by the clear sharp heresy of removing of real person, and the basic principle prescription that the nourishing for deficiency kidney is set upright mostly is peroral dosage form, and peroral dosage form injures one's stomach easily.
Three, summary of the invention
The objective of the invention is provides a kind of and has no side effect in order to overcome the deficiency of prior art, good effect, the prostatitic Chinese medicine of the treatment of external application type.
The characteristics that the present invention treats prostatitic medicine are: according to composition by weight, will: 20 parts of Radix Clematidis, 20 parts of succinums, 18 parts of Fructus Akebiae, 30 portions of Caulis Trachelospermis, 18 parts of Herba Cynomoriis, 20 parts of Herba Taraxacis, 20 parts of Herba Violaes, after crushed, cross 200 mesh sieves, mixing, after weighing, the liquor infusion of 70 degree of weight such as adding forms infusion in summer 7 days or infusion in winter 15 days.
The performance that relates to Chinese medicine in the pharmaceutical formulation of the present invention:
Radix Clematidis: expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, expectorant water, the hypochondriac lump of loosing.Because of its property is walked to scurry, the pharmacology confirms that it removes esophagus, bronchus, ureter, stomach and biliary tract etc. in addition and locate the effect of smooth muscle spasm, and stronger anti-inflammatory analgetic effect is arranged.
Succinum: nature and flavor are sweet, and are flat.Calmness, diuresis is invigorated blood circulation.
Fructus Akebiae: nature and flavor are cold in nature, bitter in the mouth.Function cures mainly liver-smoothing, qi-regulating, promoting blood circulation and stopping pain, diuresis, parasite killing.
Caulis Trachelospermi: the nature and flavor hardship is slightly cold.GUIXIN, liver, kidney channel.Function cures mainly dispelling wind and removing obstruction in the collateral, the removing heat from blood detumescence.
Herba Cynomorii: nature and flavor are sweet, temperature.Return spleen, kidney, large intestine channel.Function cures mainly kidney-replenishing, benefiting essence-blood, loosening bowel to relieve constipation.
Herba Taraxaci: nature and flavor are sweet, and little hardship is cold.The function heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.
Herba Violae: nature and flavor hardship, suffering, cold, nontoxic; GUIXIN, Liver Channel.Its mildly bitter flavor cold in nature, heat-clearing and toxic substances removing, removing heat from blood detumescence.
Liquor: abnormal smells from the patient suffering.Sweet, big heat, very toxic.
Using method: medicine of the present invention is a kind of medicine for external use.Get about 1 jin, a traditional unit of weight of the good medicine of the present invention of infusion, make the big medicated egg of Ovum Anas domestica, be placed on position, kidney cave, prostate proparea, cover, be incubated 2~3 hours, be preferably in medication at that time, in medicine, add an amount of Rhizoma Zingiberis Recens juice again with Polypropylence Sheet.Application every day 1 time, 10 days is a course of treatment.
Medicine advantage of the present invention: have no side effect good effect.
Four, the specific embodiment
In order to prove that medicine of the present invention has the prostatitic superior efficacy of treatment, the present invention has done a large amount of clinical observations, now clinical experiment is disclosed as follows:
Select case
1, alternative is a prostatitis patient.
2, age 28-68 year.
The case diagnosis standard
The traditional Chinese medical science is debated knowledge and is formulated by national unified editing traditional Chinese medical science universities and colleges teaching material;
Doctor trained in Western medicine is formulated by national unified editing doctor trained in Western medicine universities and colleges teaching material.
Therapeutic scheme
1, select case 420 examples, 210 examples are organized in treatment, matched group 210 examples.
Medicine is formed: according to composition by weight, will: 20 parts of Radix Clematidis, 20 parts of succinums, 18 parts of Fructus Akebiae, 30 portions of Caulis Trachelospermis, 18 parts of Herba Cynomoriis, 20 parts of Herba Taraxacis, 20 parts of Herba Violaes, after crushed, cross 200 mesh sieves, mixing, after weighing, the liquor infusion of 70 degree of weight such as adding forms infusion in summer 7 days or infusion in winter 15 days.
Using method:
Treatment group: get about 1 jin, a traditional unit of weight of the good medicine of the present invention of infusion, make the big medicated egg of Ovum Anas domestica, be placed on position, kidney cave, prostate proparea, cover with Polypropylence Sheet, be incubated 2 hours 40 minutes, at that time in medication, add an amount of Rhizoma Zingiberis Recens juice in medicine again, application every day 1 time was adhered to medication 10 days.
Matched group: conventional Western medicine antibiotic, Chinese medicine oral liquid treatment.
Efficacy evaluation
Efficacy assessment standard
1, recovery from illness: after finishing the course of treatment, symptom, sign disappear, and the laboratory leading indicator is recovered or be approaching normal.
2, produce effects: after finishing the course of treatment, symptom, sign disappear substantially, and the laboratory leading indicator also has clear improvement.
3, effective: after finishing the course of treatment, symptom, sign alleviate, and the laboratory leading indicator also has improvement.
4, invalid: after finishing the course of treatment, symptom, sign and other index do not have obvious improvement.
The efficacy evaluation result
There were significant differences for the two groups of total effectses in treatment back, treatment group total effective rate 98.1%, and cure-remarkable-effectiveness rate 83.3%, treatment group clinical effectiveness is apparently higher than matched group.

Claims (1)

1. treat prostatitic medicine for one kind, it is characterized in that according to composition by weight, will: 20 parts of Radix Clematidis, 20 parts of succinums, 18 parts of Fructus Akebiae, 30 portions of Caulis Trachelospermis, 18 parts of Herba Cynomoriis, 20 parts of Herba Taraxacis, 20 parts of Herba Violaes, after crushed, cross 200 mesh sieves, mixing is after weighing, the liquor infusion of 70 degree of weight such as adding forms infusion in summer 7 days or infusion in winter 15 days.
CN 200810073044 2008-12-30 2008-12-30 Medicine for treating prostatitis Expired - Fee Related CN101766734B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200810073044 CN101766734B (en) 2008-12-30 2008-12-30 Medicine for treating prostatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200810073044 CN101766734B (en) 2008-12-30 2008-12-30 Medicine for treating prostatitis

Publications (2)

Publication Number Publication Date
CN101766734A CN101766734A (en) 2010-07-07
CN101766734B true CN101766734B (en) 2011-07-27

Family

ID=42499935

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200810073044 Expired - Fee Related CN101766734B (en) 2008-12-30 2008-12-30 Medicine for treating prostatitis

Country Status (1)

Country Link
CN (1) CN101766734B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679834A (en) * 2005-01-31 2005-10-12 中国人民解放军第四军医大学药物研究所 Capsules of Tokyo violet, dandelion and flavescent sophora root and their making method
CN1895462A (en) * 2006-06-29 2007-01-17 王建辉 Nankang soft capsule for treating prostatitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679834A (en) * 2005-01-31 2005-10-12 中国人民解放军第四军医大学药物研究所 Capsules of Tokyo violet, dandelion and flavescent sophora root and their making method
CN1895462A (en) * 2006-06-29 2007-01-17 王建辉 Nankang soft capsule for treating prostatitis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
徐承祖.中医治疗前列腺增生症的思路与方法.《江西中医药》.1996,第27卷(第一期),21-23. *

Also Published As

Publication number Publication date
CN101766734A (en) 2010-07-07

Similar Documents

Publication Publication Date Title
CN102885945A (en) External traditional Chinese medicine composition for treating haemorrhoids and preparation method of external traditional Chinese medicine composition
CN107412468A (en) A kind of application of the Chinese medicine composition for treating genital system infection disease, carbon-based patch, the preparation method of carbon-based patch and carbon-based patch
CN102847021B (en) Enema for treating ulcerative colitis and preparation method thereof
CN1327875C (en) Chinese medicine formulation for treating chronic pelvic inflammation and its preparing method
CN100540044C (en) A kind of psoriasic Chinese medicine for oral administration and preparation method thereof that is used for the treatment of
CN102872300B (en) Traditional Chinese medicine for treating non-gonococcal urethritis
CN101391065B (en) Compound momordica seed pepper soup for treating urgent chronic pelvic inflammatory disease
CN102764360B (en) Traditional Chinese medicine composition for treating acute cystitis
CN103263548A (en) Embrocation for treating haemorrhoids and application thereof
CN101766734B (en) Medicine for treating prostatitis
CN103341059A (en) Chinese medicine composition for treating non-gonococcal urethritis
CN103083619B (en) Traditional Chinese medicine composition for treating biliary tract ascariasis
CN103386101B (en) Traditional Chinese medicine preparation for nonspecific cystitis treatment and preparation method thereof
CN105031487A (en) Traditional Chinese medicine composition for treating children's jaundice caused by retention of dampness in the spleen and stomach
CN100450537C (en) Chinese medicinal formulation for treating prostate hyperplasia
CN102688456B (en) Chinese medicinal composition for treating chronic prostatitis
CN107441183A (en) Treat gel foamable composition of gynaecological imflammation and its preparation method and application
CN106266391A (en) A kind of medicine for fat-eliminating slimming
CN100406043C (en) A Chinese medicinal composition for treating prostatitis
CN105233048A (en) traditional Chinese medicine for treating verumontanitis
CN104771736B (en) Treat the Chinese medicine preparation of hyperplasia of prostate
CN104474096A (en) Traditional Chinese medicine composition for treating anal eczema and preparation method of traditional Chinese medicine composition
CN103919869A (en) Traditional Chinese medicine composition for treating perianal abscess
CN105168847A (en) Traditional Chinese medicine for treating helicobacter pylori infected peptic ulcer
CN105213655A (en) A kind of Chinese medicine composition of adjuvant treatment of acute cholecystitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110727

Termination date: 20141230

EXPY Termination of patent right or utility model